BioNovelus Inc. Begins Active Solicitation Of Marijuana Growers To Test Biofungicide CR-10 For The Prevention Of Mold And Fungus On Marijuana Crops

Phoenix, Nov. 17, 2016 (GLOBE NEWSWIRE) --  / BioNovelus Inc. has begun soliciting marijuana growers to test Biofungicide CR-10 to prevent mold and fungus on marijuana crops. Our current plan is to have as many companies test the Biofungicide CR-10 in the coming months on as many varying marijuana crop fields as interested to ensure viability of the product.

"We believe Biofungicide CR-10 may be a solution to the marijuana mold and fungus issue and need more extensive testing to determine viability", said CEO Jean Ekobo, and went on to say "With the legalization of marijuana in more states and if the tests are successful, we believe that Biofungicide CR-10 could become a critical protection for the marijuana industry."

Senior chemical engineer Bjoern Fritzsche, from Rose City Laboratories in Portland, Oregon (, said on its report that on average, 15-20 percent of all cannabis tested in Oregon is being rejected due to high levels of toxic molds. In addition, senior micro biologist Steven McNalley, of Analytical 360, in Seattle ( reported similar results for the State of Washington. Mr. McNalley added that this number is much higher than the test results reveal as the 20 percent rejection rate only accounts for the final product that is submitted for testing.  According to Arcview Market Research (, "by 2020 legal cannabis sales in the United States are projected to hit $21.8 billion."

About Biofungicide CR-10 CR-10 is a proven, biodegradable, non-toxic solution that kills bacteria, fungi and spores rapidly, safely and effectively. It is a new generation of biofungicide with a unique mode of action. BioNovelus management believes that CR-10 has a broad range of uses in agricultural applications which now may include marijuana. If you are a marijuana company or know of one that would like to test CR-10 please contact us.

About BioNovelus Inc. BioNovelus, Inc. (PINKSHEETS: ONOV) is a bioscience company that honors the environment with an innovative, cost effective and disruptive technology-based solution to agricultural and water problems.

We are determined to help coffee growers keep the better tasting strain of the Arabica plant by fighting coffee rust through our "green" CR-10 instead of being forced to change to "hybrid" type plants. We feel very strongly that our "green", biodegradable product is not only better for our environment but for people who enjoy the rich flavor that comes from Arabica coffee beans, whether organic or not.

BioNovelus' primary target market is the $100Billion* plus, annual, worldwide, coffee industry. (*Source: Business Insider) Coffee Rust or "Roya" (Hemileia vastatrix), is a devastating fungus attacking the Arabica plant, currently, the coffee industry's greatest threat. Billions of dollars and hundreds of thousands of industry jobs have been lost throughout Central America since 2012. (Source: ICafé)

Forward-Looking Statements This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.

There is no assurance of if and when EPA approval will be obtained for CR-10 and various applications. There is no assurance that the marijuana plant applications will prove commercially viable.

Factors that could cause the Company's results to differ materially from forward looking statements regarding EPA approval and the efficacy of the CR-10 results a delay in EPA approval include the lack of capital needed to complete testing, the lack of experience with pursuing approval of this product and modifications that may be demanded by the EPA of the CR-10 formula. Factors that could cause lower rates of success in CR-10 eradication of fungi in coffee plantations and marijuana fields include the method and timing of applications of CR-10, the impact of heavy rain fall the strength of fungi contamination, and other environmental conditions resulting in re-infection.

Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, general business and economic conditions beyond the Company's control the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

For additional information:


Media contact: Nathalie Ekobo, Marketing & Communications Director BioNovelus, Inc. +1 602-888-3424